Evidence map›Paper›PMID 19675215›Full record

ArticleJournal of clinical microbiology2009

Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network.

S Arunmozhi Balajee, Rui Kano, John W Baddley, Stephen A Moser, Kieren A Marr, Barbara D Alexander, David Andes, Dimitrios P Kontoyiannis, Giancarlo Perrone, Stephen Peterson and 3 more

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 149 papers.

0numbers the graph read from it
0cells of the map it votes in
149citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

149 citing papers in PubMed.

  1. Article
  2. Review
  3. Nosocomial invasive Aspergillus calidoustus infection in a CAR-T cell-treated patient with concomitant Aspergillus fumigatus respiratory infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Molecular Identification ofInfection and drug resistance · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Journal of fungi (Basel, Switzerland) · 2024
    Article
  15. Article
  16. Endogenous Endophthalmitis Caused byTurkish journal of ophthalmology · 2024
    Article
  17. Review
  18. Article
  19. SystemicJournal of fungi (Basel, Switzerland) · 2024
    Article
  20. Article

89 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

S Arunmozhi BalajeeMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. fir3@cdc.gov
Rui Kano
John W Baddley
Stephen A Moser
Kieren A Marr
Barbara D Alexander
David Andes
Dimitrios P Kontoyiannis
Giancarlo Perrone
Stephen Peterson
Mary E Brandt
Peter G Pappas
Tom Chiller

Funding

Mortality in Transplant Patients with AspergillosisK23AI064613 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BADDLEY, JOHN W. · 2005 to 2009
$474k
NIAID NIH HHS K23 AI064613NIAID NIH HHS K23AI064613
6 · The paper itself

Abstract

A large aggregate collection of clinical isolates of aspergilli (n = 218) from transplant patients with proven or probable invasive aspergillosis was available from the Transplant-Associated Infection Surveillance Network, a 6-year prospective surveillance study. To determine the Aspergillus species distribution in this collection, isolates were subjected to comparative sequence analyses by use of the internal transcribed spacer and beta-tubulin regions. Aspergillus fumigatus was the predominant species recovered, followed by A. flavus and A. niger. Several newly described species were identified, including A. lentulus and A. calidoustus; both species had high in vitro MICs to multiple antifungal drugs. Aspergillus tubingensis, a member of the A. niger species complex, is described from clinical specimens; all A. tubingensis isolates had low in vitro MICs to antifungal drugs.

Indexed as

Antifungal AgentsAspergillosisAspergillusDNA, FungalDNA, Ribosomal SpacerHumansImmunocompromised HostMicrobial Sensitivity TestsSequence Analysis, DNATransplantationTubulinAntifungal AgentsDNA, FungalDNA, Ribosomal SpacerTubulin

Identifiers

PMID19675215
PMCPMC2756904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.